Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.7153
+0.0201 (2.89%)
At close: May 29, 2026, 4:00 PM EDT
0.7003
-0.0150 (-2.10%)
After-hours: May 29, 2026, 7:57 PM EDT
Pasithea Therapeutics Employees
Pasithea Therapeutics had 5 employees as of December 31, 2025. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$3,946,785
Market Cap
23.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | 1 | 25.00% | 5 | 0 |
| Dec 31, 2024 | 4 | -4 | -50.00% | 4 | 0 |
| Dec 31, 2023 | 8 | -7 | -46.67% | 8 | 0 |
| Dec 31, 2022 | 15 | 10 | 200.00% | 15 | 0 |
| Dec 31, 2021 | 5 | 2 | 66.67% | 3 | 2 |
| Jun 30, 2021 | 3 | - | - | 1 | 2 |
| Mar 31, 2021 | 3 | - | - | 1 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| NextCure | 40 |
| Werewolf Therapeutics | 39 |
| Longeveron | 38 |
| Sensei Biotherapeutics | 29 |
| Curis | 24 |
| Jasper Therapeutics | 22 |
| Cellectar Biosciences | 11 |
KTTA News
- 1 day ago - Pasithea gets orphan status for treatment of amyotrophic lateral sclerosis - TheFly
- 26 days ago - Pasithea Therapeutics appoints Kartik Krishnan as chief medical officer - TheFly
- 26 days ago - Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer - GlobeNewsWire
- 5 weeks ago - Pasithea Therapeutics announces U.S. FDA granted RPDD to PAS-004 - TheFly
- 2 months ago - Pasithea Therapeutics Announces Grant of Fast Track Designation by FDA to PAS-004 for Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Causing Significant Morbidity - GlobeNewsWire
- 3 months ago - Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 months ago - Pasithea Therapeutics provides updated timeline on PAS-004 programs - TheFly
- 4 months ago - Pasithea Therapeutics Provides Outlook on PAS-004 Clinical Programs and Data Release Timelines - GlobeNewsWire